Papillomavirus Research Update: Highlights of the Barcelona HPV 2000 International Papillomavirus Conference

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2001 Mar 17

PMID 11253126

Citations 9

Authors

F X Bosch

T Rohan

A Schneider

I Frazer

H Pfister

X Castellsague

S de Sanjose

V Moreno

L M Puig-Tintore

P G Smith

N Munoz

H zur Hausen

Affiliations

Soon will be listed here.

Abstract

The 18th international papillomavirus conference took place in Barcelona, Spain in July 2000. The HPV clinical workshop was jointly organised with the annual meeting of the Spanish Association of Cervical Pathology and Colposcopy. The conference included 615 abstracts describing ongoing research in epidemiology, diagnosis/screening, treatment/prognosis, immunology/human immunodeficiency virus, vaccine development/trials, transformation/progression, replication, transcription/translation, viral protein functions, and viral and host interactions. This leader summarises the highlights presented at the conference (the full text of the abstracts and lectures can be found at www.hpv2000.com). Relevant material in Spanish can be found at www.aepcc.org.

Citing Articles

Molecular characterization of high-risk humanpapillomavirus genotypes in women with or without cervical lesions at VIA/VILI in Kara, Togo.

Dolou E, Kuassi-Kpede A, Zohoncon T, Traore I, Katawa G, Ouedraogo A Afr Health Sci. 2022; 21(4):1715-1721.

PMID: 35283946 PMC: 8889811. DOI: 10.4314/ahs.v21i4.27.

Long-term toxicity, pharmacokinetics and immune effects of a recombinant adenovirus vaccine expressing human papillomavirus 16 E6 and E7 proteins (HPV16 E6E7-Ad5 Vac) in primates.

Wu J, Chen G, Zhuang F, Gao M, Wu C, He Z Am J Transl Res. 2018; 10(5):1539-1551.

PMID: 29887967 PMC: 5992553.

Oral infection by the Human Papilloma Virus in women with cervical lesions at a prison in São Paulo, Brazil.

Zonta M, Monteiro J, Santos Jr G, Pignatari A Braz J Otorhinolaryngol. 2012; 78(2):66-72.

PMID: 22499372 PMC: 9443820.

Cigarette smoke condensate-induced oxidative DNA damage and its removal in human cervical cancer cells.

Moktar A, Singh R, Vadhanam M, Ravoori S, Lillard J, Gairola C Int J Oncol. 2011; 39(4):941-7.

PMID: 21720711 PMC: 3760590. DOI: 10.3892/ijo.2011.1106.

Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk.

Palma S, Novelli F, Padua L, Venuti A, Prignano G, Mariani L J Cancer Res Clin Oncol. 2010; 136(7):1101-9.

PMID: 20069434 DOI: 10.1007/s00432-009-0757-3.

References

Schiffman M, Herrero R, Hildesheim A, Sherman M, Bratti M, Wacholder S . HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000; 283(1):87-93. DOI: 10.1001/jama.283.1.87. View

Stubenrauch F, Hummel M, Iftner T, Laimins L . The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J Virol. 2000; 74(3):1178-86. PMC: 111452. DOI: 10.1128/jvi.74.3.1178-1186.2000. View

Meijer C, Walboomers J . Cervical cytology after 2000: where to go?. J Clin Pathol. 2000; 53(1):41-3. PMC: 1731046. DOI: 10.1136/jcp.53.1.41. View

zur Hausen H . Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000; 92(9):690-8. DOI: 10.1093/jnci/92.9.690. View

Kuhn L, Denny L, Pollack A, Lorincz A, Richart R, Wright T . Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst. 2000; 92(10):818-25. DOI: 10.1093/jnci/92.10.818. View

Ramoz N, Taieb A, RUEDA L, Montoya L, Bouadjar B, Favre M . Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol. 2000; 114(6):1148-53. DOI: 10.1046/j.1523-1747.2000.00996.x. View

Rozendaal L, Westerga J, van der Linden J, Walboomers J, Voorhorst F, Risse E . PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol. 2000; 53(8):606-11. PMC: 1762926. DOI: 10.1136/jcp.53.8.606. View

Salmon J, Nonnenmacher M, Caze S, Flamant P, CROISSANT O, Orth G . Variation in the nucleotide sequence of cottontail rabbit papillomavirus a and b subtypes affects wart regression and malignant transformation and level of viral replication in domestic rabbits. J Virol. 2000; 74(22):10766-77. PMC: 110951. DOI: 10.1128/jvi.74.22.10766-10777.2000. View

Wells S, Francis D, Karpova A, Dowhanick J, Benson J, Howley P . Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J. 2000; 19(21):5762-71. PMC: 305788. DOI: 10.1093/emboj/19.21.5762. View

10.

Holowaty P, Miller A, Rohan T, To T . Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999; 91(3):252-8. DOI: 10.1093/jnci/91.3.252. View

11.

Manos M, Kinney W, Hurley L, Sherman M, Kurman R, Ransley J . Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999; 281(17):1605-10. DOI: 10.1001/jama.281.17.1605. View

12.

Nobbenhuis M, Walboomers J, Helmerhorst T, Rozendaal L, Remmink A, Risse E . Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999; 354(9172):20-5. DOI: 10.1016/S0140-6736(98)12490-X. View

13.

Walboomers J, Jacobs M, Manos M, Bosch F, Kummer J, Shah K . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189(1):12-9. DOI: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. View

14.

Harwood C, McGregor J, Proby C, Breuer J . Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol. 1999; 52(4):249-53. PMC: 501326. DOI: 10.1136/jcp.52.4.249. View

15.

Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A . A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess. 1999; 3(14):i-iv, 1-196. View

16.

Vernon S, Unger E, Williams D . Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol. 2000; 38(2):651-5. PMC: 86168. DOI: 10.1128/JCM.38.2.651-655.2000. View